Topic
Biotech
244 published works
IP Intelligence
Biotech Patent Dispute Between Academics That Is Far From Academic
By Allen Sokal
On December 6, 2016, the parties to the complex and soon-to-be departed world of patent interferences orally argued their positions on motions in what has been described as the “biotech…
The Right Coast
Living cells are coaxed into using silicon to make material for TV screens | Daily Mail Online
By mutating bacterial DNA, the team at CalTech in San Diego has produced an enzyme which can bind silicon and carbon.via www.dailymail.co.ukCalTech is in Pasadena, not San Diego. I can't…
Family Law Prof Blog
Designer Babies? Most Say “No Thanks”
By Family Law
From the International Business Times:American adults have express distrust in regard to the emerging field of biomedical technologies used for human enhancement. A survey completed by the Pew Research Center…
PTABWatch
Patent Ineligibility Under §101 Continues Slow Ooze Over More Territory
By Katherine L. Neville, Ph.D.
Biotech companies have increasingly found themselves the target of IPRs, and we have discussed this in some of our past posts. Meanwhile, in the District Courts, biotech companies are defending…
The Faculty Lounge
The Future of Health Law and Policy: Petrie-Flom Center 10th Anniversary Conference
On March 29, current affiliates and alums (including myself) of Harvard Law's Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics will converge on Cambridge for a day-long conference to…
The Healthcare Investor
Healthcare & Life Sciences Private Equity Deal Tracker: Atreca Secures $56 Million in Funding
Atreca has announced it has secured $56 million in series A funding. Atreca, based in Redwood City, California, is a privately held biotechnology company developing therapeutics drawn from human immune…
The Healthcare Investor
Healthcare & Life Sciences Private Equity Deal Tracker: Galera Therapeutics Secures $37 Million in Financing
Galera Therapeutics has announced it has raised $37 million in series B financing. Galera, headquartered in Malvern, Pa., is a clinical-stage biotechnology company focused on the development of drugs targeting…
The Right Coast
Bolt Threads Hopes Genetically Engineered Yeast Can Churn Out Versatile Fibers for Clothes of the Future | MIT Technology Review
Two of its founders are Dan Widmaier and David Breslauer, who have been working on the problem since they were grad students at the University of California, San Francisco, and…
The Right Coast
Peter Thiel of Founders Fund Outlines Biotech Investment Ideas | MIT Technology Review
The prominent Silicon Valley venture capitalist s investment fund has put its largest ever bet on a biotech company called Stemcentrx, a private and all-but-unheard-of San Francisco company developing cancer…
Food Safety News
USDA Gives GE Potato ‘Nonregulated’ Status
By News Desk
Officials with the U.S. Department of Agriculture's Animal and Plant Health Inspection Service (APHIS) announced Friday, Aug. 28, 2015, that they had made a determination of "nonregulated status" for the Innate…